Barrios et al. found that FGF-2 regulates partial re-differentiation in some breast cancer cell lines, reduces motility and invasion, upregulates α5β1 integrin expression and induces pro-survival characteristics through the PI3K/AKT signaling pathway. The gene discussed is AKT1; the disease is breast carcinoma.